IP Library › Granted Patent US 9,480,554
Granted Patent B2
US 9,480,554 · App. 14/714,748 · Granted Nov 1, 2016

Tissue marking implant

Inventor: John D. Corbitt, Jr. (Lake Worth, FL)
Assignee: SenoRx, Inc.
A61F2/12A61L27/18A61L27/56A61L27/58A61B2090/3908A61F2/0059A61F2/0077A61F2210/0004A61F2210/0066
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,480,554
App. No.
14/714,748
Granted
Nov 1, 2016
Kind
B2
Abstract

A method for marking a surgically formed cavity in a patient includes providing an implant comprising a matrix material and a marking material, the matrix material configured to be elastically compressible; modifying the shape and size of the implant to fit the shape and size of the surgically formed cavity in the patient, the implant being configured to fill the surgically formed cavity and support tissue surrounding the surgically formed cavity and to allow in-growth of fibrous tissue into and replace at least a portion of the matrix material; and inserting the implant into the surgically formed cavity.

Claims (31)

1. A method for marking a surgically formed cavity in a patient, comprising:

providing an implant comprising a matrix material and a marking material, the matrix material configured to be elastically compressible;

modifying the shape and size of the implant to fit the shape and size of the surgically formed cavity in the patient, the implant being configured to fill the surgically formed cavity and support tissue surrounding the surgically formed cavity and to allow in-growth of fibrous tissue into and replace at least a portion of the matrix material; and

inserting the implant into the surgically formed cavity.

2. The method of claim 1 , comprising inserting a dye into the matrix material.

3. The method of claim 1 , wherein the matrix material comprises one of a foam or sponge, and is at least partially resorbable.

4. The method of claim 1 , wherein the matrix material comprises a foamed bioabsorbable protein.

5. The method of claim 1 , wherein the matrix material comprises of a foamed collagen.

6. The method of claim 1 , comprising inserting at least one medicinal, therapeutic, or diagnostic substance into the matrix material.

7. The method of claim 6 , wherein the at least one medicinal, therapeutic, or diagnostic substance is selected from the group consisting of radiation materials, antibiotics, chemotherapies, cancer therapeutics, hemostatic materials, hormone therapeutics, and radiographic markers.

8. The method of claim 1 , comprising surrounding the matrix material with a shell.

9. The method of claim 8 , wherein the shell comprises a compressed matrix material.

10. A method for forming an implant for marking a surgically formed cavity in a patient, comprising:

providing a matrix material and a marking material to form an implant, the matrix material configured to be elastically compressible; and

modifying the shape and size of the implant to fit the shape and size of the surgically formed cavity in the patient, the implant being configured to fill the surgically formed cavity and support tissue surrounding the surgically formed cavity and to allow in-growth of fibrous tissue into and replace at least a portion of the matrix material.

11. The method of claim 10 , comprising inserting a dye into the matrix material.

12. The method of claim 10 , wherein the matrix material comprises one of a foam or sponge, and is at least partially resorbable.

13. The method of claim 10 , wherein the matrix material comprises a foamed bioabsorbable protein.

14. The method of claim 10 , wherein the matrix material comprises of a foamed collagen.

15. The method of claim 10 , comprising inserting at least one medicinal, therapeutic, or diagnostic substance into the matrix material.

16. The method of claim 15 , wherein the at least one medicinal, therapeutic, or diagnostic substance is selected from the group consisting of radiation materials, antibiotics, chemotherapies, cancer therapeutics, hemostatic materials, hormone therapeutics, and radiographic markers.

17. The method of claim 10 , comprising surrounding the matrix material with a shell.

18. The method of claim 17 , wherein the shell comprises a compressed matrix material.

19. A method of operating a marker delivery device for marking a surgically formed cavity in a patient, comprising:

providing a delivery cannula having a distal discharge opening;

providing an implant comprising a matrix material and a marking material, the matrix material being configured to be elastically compressible and configured to allow in-growth of fibrous tissue into and replace at least a portion of the matrix material after implantation in the surgically formed cavity;

forming the implant to a shape and a size of the surgically formed cavity to fill the surgically formed cavity and support tissue surrounding the surgically formed cavity;

compressing the implant to fit within the delivery cannula;

inserting the delivery cannula into the patient until the distal discharge opening of the delivery cannula is located within the surgically formed cavity; and

discharging the implant from the delivery cannula through the distal discharge opening, wherein the matrix material expands such that the implant fills the surgically formed cavity.

20. The method of claim 19 , comprising surrounding the matrix material with a shell.

Continuity (12)
Continuation 14166328 · Jan 28, 2014
Continuation 13426061 · Mar 21, 2012
Continuation 12965405 · Dec 10, 2010
Continuation 12589413 · Oct 23, 2009
Division 11108785 · Apr 19, 2005
Continuation In Part 10627718 · Jul 28, 2003
Division 09828806 · Apr 10, 2001
Continuation In Part 09169351 · Oct 9, 1998
Provisional Application 60061588 · Oct 10, 1997
Provisional Application 60077639 · Mar 11, 1998
Provisional Application 60091306 · Jun 30, 1998
Related Publication 20150257872A1 · Sep 17, 2015